- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Elgene Chemical
Total 2122 results
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Celgene CorporationCompletedHealthy SubjectsUnited States
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Celgene CorporationCompletedHealthy VolunteersUnited States
-
Celgene CorporationWithdrawn
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
Celgene CorporationUnknown
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationTerminatedMyeloid LeukemiaUnited States
-
Celgene CorporationCompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Prostate CancerUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
University of California, DavisAmino Up Chemical CompanyCompletedCardiovascular Health
-
Yonsei UniversitySK Chemicals Co., Ltd.CompletedAcute Kidney InjuryKorea, Republic of
-
Monell Chemical Senses CenterPennsylvania Department of HealthCompleted
-
Mackay Memorial HospitalSeda Chemical Products Co., Ltd.UnknownObstructive Sleep Apnea | Sleep-disordered BreathingTaiwan
-
CelgeneNot yet recruiting
-
CelgeneNot yet recruiting
-
CelgeneRecruiting
-
CelgeneNot yet recruitingLarge B-cell LymphomaUnited States, Canada, Argentina, Australia, Austria, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Poland, Portug... and more
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
CelgeneRecruitingLymphoma, Non-HodgkinUnited States, Korea, Republic of, China, Canada, France, Spain, Denmark, Brazil, Italy, Argentina, Chile, Israel, United Kingdom, Belgium, Austria
-
CelgeneRecruitingNeoplasmsUnited States, Belgium, Spain, Switzerland, Canada, France, Germany, Japan, Finland, United Kingdom, Austria, Italy, Netherlands, Norway, Sweden
-
CelgeneRecruitingMultiple MyelomaKorea, Republic of
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Primary MyelofibrosisUnited States, Puerto Rico
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
CelgeneActive, not recruitingGlioblastoma | AstrocytomaUnited States, Spain
-
CelgeneActive, not recruitingCrohn DiseaseUnited States, Italy, Germany, Russian Federation, Argentina, Australia, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Finland, France, Georgia, India, Ireland, Israel, Korea, Republic... and more
-
CelgeneTerminatedNon Small Cell Lung CancerUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
CelgeneActive, not recruitingSmall Cell Lung CarcinomaFrance, Italy, Spain
-
CelgeneTerminatedNeoplasms | Lymphoma, Non-HodgkinFrance, Italy, Japan, Spain, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneCompleted
-
CelgeneCompletedMultiple SclerosisUnited States, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Moldova, Republic of, New Zealand, Poland, Portugal, Romania, Serbia, Slovakia, South... and more
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
-
CelgeneActive, not recruitingEosinophilic GastroenteritisJapan
-
CelgeneCompletedLymphoma, Follicular | Myelodysplastic Syndromes | Lymphoma, Mantle-CellKorea, Republic of
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
CelgeneActive, not recruitingMultiple SclerosisUnited States, Canada, Puerto Rico
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Belgium, Germany, Japan, Netherlands, France, Sweden, Italy, Spain, Switzerland, United Kingdom, Finland
-
CelgeneCompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinFrance, Italy, Netherlands
-
CelgeneActive, not recruitingMyelodysplastic SyndromesChina, Japan
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinFrance, Canada, United States, Spain
-
CelgeneActive, not recruitingUlcerative ColitisUnited States, Germany, Greece, United Kingdom, Hungary, Belgium, Slovakia, Bulgaria, Italy, Australia, Israel, Belarus, Romania, Ukraine
-
CelgeneCompletedDigestive System Diseases | Neoplasms | Neoplasms by Site | Endocrine System Diseases | Digestive System Neoplasms | Endocrine Gland Neoplasms | Pancreatic Neoplasms | Pancreatic Diseases | Gemcitabine | Antimetabolites, AntineoplasticUnited States, Korea, Republic of, Canada, France, Spain, Belgium, Austria, Czechia, Denmark, Italy, Hong Kong, Singapore, Taiwan, Germany, Hungary, Australia, United Kingdom, Portugal, Ireland, Finland, Netherlands